Revenue: The sum of all revenue fields included for a company's operating activities.
Oxford BioMedica (OXBDF) had Revenue of $111.38M for the most recently reported fiscal year, ending 2023-12-31.
| Income Statement Financials | |
|
Revenue |
$111.38M |
$-195.90M |
|
$61.96M |
|
$49.42M |
|
$340.47M |
|
$-229.09M |
|
$-5.41M |
|
$-234.51M |
|
$-234.51M |
|
$-229.08M |
|
$-229.08M |
|
$-229.08M |
|
$-229.08M |
|
$-229.09M |
|
$-193.38M |
|
96.56M |
|
96.56M |
|
$-2.03 |
|
$-2.03 |
|
| Balance Sheet Financials | |
$175.80M |
|
$94.15M |
|
$138.09M |
|
$313.89M |
|
$55.12M |
|
$134.10M |
|
$161.95M |
|
$217.07M |
|
$96.82M |
|
$58.28M |
|
$96.82M |
|
96.80M |
|
| Cash Flow Statement Financials | |
$-35.47M |
|
$3.49M |
|
$-15.80M |
|
$175.74M |
|
$129.01M |
|
$-46.73M |
|
-- |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
3.19 |
|
-- |
|
-- |
|
0.58 |
|
1.43 |
|
44.37% |
|
-205.69% |
|
-205.69% |
|
-173.63% |
|
-210.55% |
|
-175.89% |
|
$-37.27M |
|
-- |
|
-- |
|
-- |
|
0.35 |
|
3.87 |
|
3.62 |
|
100.86 |
|
-236.61% |
|
-393.06% |
|
-72.98% |
|
-99.20% |
|
$1.00 |
|
$-0.39 |
|
$-0.37 |
|